📝 Nirman Agri Genetics Limited — results explained
Quarter ended March 2026 (Q4 FY26)
Nirman Agri Genetics Limited reported revenue of ₹50 crore for the quarter ended March 2026 (Q4 FY26), down 59.7% from ₹124 crore in the same quarter last year.
Net profit fell 78.6% year-on-year to ₹3 crore, from ₹14 crore. Earnings per share (EPS) came in at ₹3.78.
Operating profit stood at ₹4 crore — an operating margin (OPM) of 8.0%, compared with 12.1% in the year-ago quarter.
Full year and trailing twelve months
On a trailing-twelve-month (TTM) basis, revenue stands at ₹196 crore with a net profit of ₹18 crore.
Valuation snapshot
At the current price of ₹27.80, NIRMAN has a market capitalisation of ₹22 crore and a trailing P/E of about 1.2.
Within the Other Agricultural Products industry, it is the 12th-largest of the 59 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 44.34%, foreign institutional investors (FIIs) 0.02%, domestic institutional investors (DIIs) 0.00%, public shareholders 55.65% of Nirman Agri Genetics Limited.